22 May 2013
Keywords: celltran, raises, l2, private, funding, sheffield, uk-based
Article | 15 August 2005
CellTran, the Sheffield, UK-based wound-care company and a part of the Biofusion portfolio, has raised L2.7 million ($4.9 million) in a
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
15 August 2005
28 March 2005
© 2013 thepharmaletter.com